Shire sales fall as competition hits Adderall

0

LONDON (SHARECAST) - Pharmaceutical group Shire saw sales and earnings fall in the first quarter of 2010 as its ADHD treatment Adderall felt the impact of competition following the expiration of its exclusivity.

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!